Breaks Categories: News

WednesdayJan 20, 2021 2:53 pm

CBDNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Appoints C.A. Fortune E-Comm to Represent Entire Alkaline88 Non-CBD Beverage Line

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has announced a partnership with C.A. Fortune E-Comm, the online arm of C.A. Fortune, to offer WTER’s A88 family of beverages across various e-commerce platforms. The partnership is effective Jan. 21, 2021, and platforms include Amazon.com, Walmart.com, Kroger.com, Thrive.com, Boxed.com and zulilly.com among others. WTER is a producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products sold under the brand names Alkaline88(r), A88 Infused(TM), and A88CBD(TM) respectively. In the announcement, WTER noted that the C.A. E-Comm team includes account representatives, inventory specialists, content specialists and data analysts. These experts will assist…

Continue Reading

TuesdayJan 19, 2021 3:05 pm

CBDNewsBreaks – Grapefruit USA, Inc. (GPFT) Announcement Reflects on Steady Growth in Market Cap, Disruptive Hourglass(TM) Time Release THC+CBD Delivery Cream

Grapefruit USA, Inc. (OTCQB: GPFT), a premiere fully licensed California-based cannabis company, recently updated and clarified recent developments concerning its patented breakthrough, disruptive Hourglass(TM) time release THC+ Cannabinoid delivery cream. Grapefruit entered into an Exclusive License and Supply Agreement with Zylö Therapeutics Inc., of Greenville, S.C. on July 27, 2020, marking the successful completion of the seventeen-month development of Hourglass(TM), the only topical delivery technology capable of efficaciously crossing the transdermal barrier. Commenting on the steady growth in market capitalization and daily trading volume, Bradley J. Yourist, Grapefruit's CEO stated, "It has been satisfying to watch our market capitalization grow…

Continue Reading

TuesdayJan 19, 2021 10:59 am

CBDNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Update on THC, Plans for Canadian Market Launch

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has made advancements on its work on a proprietary yeast strain for the production of Tetrahydrocannabinol ("THC"); the company also announced plans to commercially launch the product in the highly regulated, legal Canadian market. Willow’s Canadian-based R&D (“R&D”) team has developed a proprietary yeast strain along with a process to produce THC; the company is eyeing a pilot scale run by the end of 2021. Willow is operating under the believe that a significant number of consumer product…

Continue Reading

ThursdayJan 14, 2021 12:14 pm

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Enters Exclusive Sales Agreement; Offers Hemp, CBD Products in UK

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has finalized an exclusive sales agreement with Elements of Green, a European eCommerce marketplace for hemp CBD products. The agreement outlines the steps for PLUS to offer its products in the United Kingdom. Based on the agreement, PLUS Grapefruit CBD Uplift and Blueberry CBD Balance gummies, which are 100% hemp, are now available in the UK exclusively through Elements of Green. Elements of Green is a European eCommerce marketplace for lab-tested CBD products and offers an impressive lineup of premium hemp-based CBD products in…

Continue Reading

ThursdayJan 14, 2021 11:06 am

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Highly Dutch Brand, Adds Amsterdam Sativa

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has added to its mainstream brand. The company unveiled three different formats —  3.5g, 15g, and 28g — of Amsterdam Sativa, available in its mainstream Highly Dutch product line. The new offerings feature organically grown, high-THC Sativa flower and is a direct response to increasing consumer demand for organic cannabis products. The new products will be available in Alberta, Saskatchewan, Manitoba, Ontario, Quebec and Newfoundland. Offering THC levels of up to 20%, Highly Dutch’s Amsterdam Sativa is organically grown and features sweet floral flavors with punchy…

Continue Reading

TuesdayJan 12, 2021 11:01 am

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Becomes One of First Publicly Traded Companies to Receive USDA Organic Certification for CBD Tinctures

HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received USDA Organic Certification for its HempFusion CBD tinctures; the exclusive line of tinctures offers products with potency from 150mg (5mg per serving) to 1,500mg (50mg per serving) of CBD per bottle. HempFusion is one of the first publicly traded CBD companies to receive the certification; the distinction is significant because organic products generally represent some of the highest quality products available. The process to certify its tinctures as USDA Organic started in 2018, and involve providing detailed documentation for every…

Continue Reading

ThursdayJan 07, 2021 11:38 am

CBDNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Listing on OTC Markets, Now Trading Under PRXT Symbol

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, recently received approval from OTC Markets and is  now trading under the ticker symbol PRXTF (“PRXTF”). OTC Markets is recognized for offering Canadian companies the benefits of being publicly traded in the United States but with lower cost and complexity than a U.S. exchange listing. To be eligible to list on the OTC Exchange, Canadian companies must undergo an annual verification and management certification process and be up-to-date with their SEDAR reporting. Moving forward, Pure Extracts will continue to trade on…

Continue Reading

WednesdayJan 06, 2021 2:25 pm

CBDNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Announces DTC Eligibility

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has obtained eligibility with the Depository Trust Company “DTC” for its common shares listed on the OTCQB. The DTC is a stock depository that facilitates and simplifies electronic trading of securities in the United States. According to the update, Pac Roots common shares, listed on the OTCQB under the symbol PACRF, are now eligible for electronic clearing and settlement through DTC’s automated processes. The electronic method of clearing securities speeds up the receipt of stock and cash…

Continue Reading

WednesdayJan 06, 2021 11:18 am

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Completes IPO, Starts Trading on Toronto Stock Exchange

HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has completed its initial public offering (“IPO”), In addition, the company announced that, as of Jan. 6, 2021, it has begun trading on the Toronto Stock Exchange under three different symbols: CBD.U for common shares, CBD.WT.V for the warrants and CBD.WT.U for the 2019 warrants. The IPO comprised 7 million common shares, offered at $1 per share, for gross proceeds of $7 million, and 10 million units of the company for gross proceeds of $10 million. “We are incredibly excited to have…

Continue Reading

TuesdayDec 22, 2020 12:45 pm

CBDNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Completion of Patient Enrollment for Study of Cannabidiol Lotion for Eczema Treatment

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products, has completed patient enrollment in its upcoming clinical study of JW-100, its proprietary cannabidiol lotion formulation for the treatment of atopic dermatitis, or eczema. The study is designed to investigate the efficacy and safety of JW-100. JUPW enrolled 66 patients for the multi-center, double-blinded, placebo-controlled trial. Study participants will be randomly selected to receive one of three topical formulations, including a placebo, at least twice daily. Data from the study is expected in Q1 2021. "We are eager to see the results of this trial,…

Continue Reading